Pages that link to "Q50817416"
Jump to navigation
Jump to search
The following pages link to Clinical and Translational Radiation Oncology (Q50817416):
Displaying 50 items.
- Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey. (Q51415449) (← links)
- Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? (Q51415582) (← links)
- Retrospective assessment of MRI-based volumetric changes of normal tissues in glioma patients following radio(chemo)therapy. (Q51733040) (← links)
- Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer (Q51733043) (← links)
- Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome. (Q52338512) (← links)
- Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. (Q52385231) (← links)
- Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era. (Q52624075) (← links)
- The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP). (Q52624077) (← links)
- SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy. (Q52624081) (← links)
- Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. (Q52624083) (← links)
- Effect of heterogeneous radio sensitivity on the survival, alpha beta ratio and biologic effective dose calculation of irradiated mammalian cell populations. (Q52624085) (← links)
- Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. (Q52624089) (← links)
- PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT). (Q52674758) (← links)
- Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs. (Q52721513) (← links)
- Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer. (Q52723380) (← links)
- Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines. (Q52723382) (← links)
- P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients. (Q52723384) (← links)
- Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study. (Q52723387) (← links)
- Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation. (Q52794306) (← links)
- SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma. (Q52802449) (← links)
- PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status. (Q52802452) (← links)
- The role of Next-Generation Sequencing in tumoral radiosensitivity prediction. (Q52805099) (← links)
- Significant tumor shift in patients treated with stereotactic radiosurgery for brain metastasis. (Q52842249) (← links)
- Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans. (Q52920293) (← links)
- Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy. (Q53176639) (← links)
- First reported treatment of aggressive hemangioma with intraoperative radiation therapy and kyphoplasty (Kypho-IORT). (Q53550985) (← links)
- The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo. (Q53596358) (← links)
- Clinical and Translational Radiation Oncology, a new player among the radiation oncology journals. (Q53620815) (← links)
- Barriers to radiotherapy access at the University College Hospital in Ibadan, Nigeria. (Q53697644) (← links)
- The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. (Q53823206) (← links)
- The impact of the IGF-1 system of cancer cells on radiation response - An in vitro study. (Q54118814) (← links)
- Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication. (Q54246266) (← links)
- Radiomic analysis in prediction of Human Papilloma Virus status. (Q54246270) (← links)
- Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. (Q54267061) (← links)
- Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review. (Q54933769) (← links)
- Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report. (Q54940866) (← links)
- Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer. (Q54942085) (← links)
- Perspectives on medical education in radiation oncology and the role of the ESTRO School. (Q54962409) (← links)
- A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response. (Q54963405) (← links)
- Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study. (Q54980429) (← links)
- Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO). (Q54982410) (← links)
- Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer. (Q55001587) (← links)
- Prospective analysis of in vivo landmark point-based MRI geometric distortion in head and neck cancer patients scanned in immobilized radiation treatment position: Results of a prospective quality assurance protocol. (Q55002679) (← links)
- Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR pathways. (Q55011926) (← links)
- Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer. (Q55017229) (← links)
- Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. (Q55023905) (← links)
- Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy. (Q55031163) (← links)
- The posterior cerebellum, a new organ at risk? (Q55032819) (← links)
- Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study. (Q55066004) (← links)
- Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy. (Q55078800) (← links)